Cargando…
Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review
BACKGROUND: Six distinct genetic variants (genotypes 1 − 6) of hepatitis C virus (HCV) exist globally. Certain genotypes are more prevalent in particular countries or regions than in others but, globally, genotype 3 (GT3) is the second most common. Patients infected with HCV GT1, 2, 4, 5 or 6 recove...
Autores principales: | Fathi, Hosnieh, Clark, Andrew, Hill, Nathan R., Dusheiko, Geoffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691805/ https://www.ncbi.nlm.nih.gov/pubmed/29145802 http://dx.doi.org/10.1186/s12879-017-2820-z |
Ejemplares similares
-
Towards the elimination and eradication of hepatitis B
por: Dusheiko, Geoffrey
Publicado: (2015) -
Hepatitis B prevalence in pregnant women in China: Progress and realities
por: Dusheiko, Geoffrey
Publicado: (2021) -
Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries
por: Mitchell, Tim, et al.
Publicado: (2022) -
Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
por: Mir, Fazia, et al.
Publicado: (2017) -
Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges
por: Shahnazarian, Vahe, et al.
Publicado: (2018)